SLNSW-Phase-I/II study to evaluate dose limiting toxici...-TN_cdi_proquest_journals_220506897

Phase-I/II study to evaluate dose limiting toxicity, maximum tolerated dose, and tolerability of bendamustine HCl in pre-treated patients with B-chronic lymphocytic leukaemia (Binet stages B and C) requiring therapy

Full title: Phase-I/II study to evaluate dose limiting toxicity, maximum tolerated dose, and tolerability of bendamustine HCl in pre-treated patients with B-chronic lymphocytic leukaemia (Binet stages B and C) requiring therapy

Author/creator: Lissitchkov, T, Arnaudov, G, Peytchev, D, Merkle, Kh.

Call Numbers:

Record Identifier: TN_cdi_proquest_journals_220506897

Language: English

Formats: Articles

Publishers: Germany: Springer

Permalink: https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_220506897

Articles

Articles

Export this record

Export selected records

  • Export to excel
  • Permalink

    • Export record to excel

    File type to download

    Beta version

    Record title

    Phase-I/II study to evaluate dose limiting toxicity, maximum tolerated dose, and tolerability of bendamustine HCl in pre-treated patients with B-chronic lymphocytic leukaemia (Binet stages B and C) requiring therapy

    Record identifier

    TN_cdi_proquest_journals_220506897

    Record permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_220506897

    Share

    Phase-I/II study to evaluate dose limiting toxicity, maximum tolerated dose, and tolerability of bendamustine HCl in pre-treated patients with B-chronic lymphocytic leukaemia (Binet stages B and C) requiring therapy

    ACCESS
    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_220506897

    Phase-I/II study to evaluate dose limiting toxicity, maximum tolerated dose, and tolerability of bendamustine HCl in pre-treated patients with B-chronic lymphocytic leukaemia (Binet stages B and C) requiring therapy

    Full title

    Phase-I/II study to evaluate dose limiting toxicity, maximum tolerated dose, and tolerability of bendamustine HCl in pre-treated patients with B-chronic lymphocytic leukaemia (Binet stages B and C) requiring therapy

    Author / Creator

    Lissitchkov, T ; Arnaudov, G ; Peytchev, D ; Merkle, Kh

    Publisher

    Germany: Springer

    Journal title

    Journal of cancer research and clinical oncology, 2006, Vol.132 (2), p.99-104

    Record Identifier

    TN_cdi_proquest_journals_220506897

    Language

    English

    Formats

    Articles

    Publication information

    Publisher

    Subjects

    Subjects and topics

    Aged Antineoplastic Agents - administration & dosage Antineoplastic Agents - adverse effects Bendamustine Hydrochloride Chemotherapy Clinical trials Drug Administration Schedule Drug dosages Female Follow-Up Studies Humans Leukemia Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy Leukemia, Lymphocytic, Chronic, B-Cell - pathology Male Middle Aged Neoplasm Staging Nitrogen Mustard Compounds - administration & dosage Nitrogen Mustard Compounds - adverse effects Pharmacology Time Factors Toxicity Treatment Outcome

    More information

    — SCOPE AND CONTENTS

    Contents

    — ALTERNATIVE TITLES

    Full title

    — AUTHORS, ARTISTS AND CONTRIBUTORS

    Author / Creator

    Identifiers

    — PRIMARY IDENTIFIERS

    Record Identifier

    TN_cdi_proquest_journals_220506897

    Permalink

    https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_220506897

    — OTHER IDENTIFIERS

    ISSN

    E-ISSN

    DOI

    How to access this item

    Online

    1 item

    How to access?

    Login with a Library card

    Full text available >

    About resource >

    View in old catalogue

    Connecting people and collections